Abstract:BACKGROUND AND AIMS:Runx family transcription factors are integral components of transforming growth factor-beta signaling pathways and have been implicated in cell cycle regulation, differentiation, apoptosis, and malignant transformation. The silencing of tumor suppressor genes by aberrant hypermethylation occurs frequently in human cancer. It has been noted previously that Runx3 is regarded as an important tumor suppressor gene.METHODS:Reverse transcription polymerase chain reaction was used to measure Runx3 and the DNA methyltransferase 1 (Dnmt1) messenger RNA (mRNA) expression level of paired samples of primary gastric cancer and corresponding non-cancerous gastric mucosae, which were obtained from surgically resected specimens of 70 patients. Western blot was used to detect the expression of Runx3 at protein levels. The promoter methylation status was measured by using methylation-specific polymerase chain reaction. We used Annexin V-FITC/PI assay to detect cell apoptosis, and the cell cycle was also analyzed. In order to examine the cell cycle and/or apoptosis, we determined p27 and caspase 3 expression by immunohistological analysis.RESULTS:Our results demonstrate a loss or substantial decrease of Runx3 expression in 70 cases of gastric tumors as compared with that in normal gastric mucosa (0.5749 +/- 0.3580 vs 1.7252 +/- 0.4085, P < 0.05). The protein levels of the Runx3 gene were significantly lower in gastric cancers than those in adjacent normal tissues. The hypermethylation of Runx3 was involved in 50% (28/56) of gastric cancer tissues, which had reduced Runx3 mRNA expression. The differences of the Dnmt1 mRNA level were significant between the methylated and unmethylated Runx3 cancerous groups. Runx3 methylation was significantly correlated with increased Dnmt1 (r = 0.64, P < 0.01). Enforced restoration of Runx3 expression led to the induction of cell apoptosis and upregulation of p27 and caspase3 expression in vitro.CONCLUSIONS:Our results suggest that a decrease of Runx3 expression by DNA hypermethylation is frequently associated with the evolution of gastric cancer. Runx3 was an independent prognostic factor and a potential therapeutic target for gastric cancer.

Runx3 Suppresses Gastric Cancer Metastasis Through Inactivation Of Mmp9 By Upregulation Of Timp-1

Runx3 Inhibits The Expression Of Vascular Endothelial Growth Factor And Reduces The Angiogenesis, Growth, And Metastasis Of Human Gastric Cancer

Prognostic significance of RUNX3 expression in human melanoma.

Tumor Suppressor Gene Runx3 Sensitizes Gastric Cancer Cells to Chemotherapeutic Drugs by Downregulating Bcl‐2, MDR‐1 and MRP‐1

RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9

RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells.

RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.

RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13

RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer.

Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis

Runx3 Mediates Suppression Of Tumor Growth And Metastasis Of Human Ccrcc By Regulating Cyclin Related Proteins And Timp-1

Inhibition of the Growth and Metastasis of Human Colon Cancer by Restoration of RUNX3 Expression in Cancer Cells.

RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway

RUNX3 Expression is Lost in Glioma and Its Restoration Causes Drastic Suppression of Tumor Invasion and Migration

Hypermethylation Downregulates Runx3 Gene Expression and Its Restoration Suppresses Gastric Epithelial Cell Growth by Inducing P27 and Caspase3 in Human Gastric Cancer

RUNX3, a Novel Tumor Suppressor, is Frequently Inactivated in Gastric Cancer by Protein Mislocalization.

EFFECTS OF RUNX3 ON CELL TURNOVER IN GASTRIC CANCER AND ITS PROGNOSTIC VALUE

Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer

Identification of SPINT3 as a Metastatic Suppressor in Gastric Cancer Through Induction of TGF-β1 Secretion

Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3

RUNX3 Directly Interacts with Intracellular Domain of Notch1 and Suppresses Notch Signaling in Hepatocellular Carcinoma Cells